GH Research PLC (GHRS NASDAQ) stock market data APIs
$20.356
0.39(1.9%)
as of November 3, 2026
Try our APIs with
free plan!
GH Research PLC Financial Data Overview
Price chart is built with
Anychart
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Prev. Close
20.356
Open
20.7475
High
21.3033
Low
20.2422
52 wk Range
12.04-31.439
Market Cap
1 407 M
Shares Outstanding
68 642 K
Beta
1.324
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with GH Research PLC (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get GH Research PLC data using free add-ons & libraries
Get GH Research PLC Fundamental Data
GH Research PLC Fundamental data includes:
- Net Revenue:
- EBITDA: -71 329 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-05
- EPS/Forecast: -0.27
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GH Research PLC News
New
GH Research (GHRS) Stock Looks Fully Priced As Book Value Questions Linger
GH Research has delivered a powerful share price run in recent years, which puts fresh attention on whether the current market value lines up with the company's book value. With the stock recently clo...
FDA names acting heads of drug and vaccine units to permanent roles
[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House ad...
Notable healthcare headlines for the week: UnitedHealth, J&J, and Intuitive Surgical in focus
Wall Street's major averages ended lower on Friday as global technology stocks declined, led by semiconductors and the debut of Moonshot AI's Kimi-K3, which dragged down investor sentiment. The bench...
Stocks making the biggest moves midday: Manpower, Abbott, UnitedHealth, TSMC & more
Check out the companies making the biggest moves in midday trading: Abbott Laboratories – The maker of Ensure nutrition shakes jumped almost 11%. Abbott raised its full-year guidance for adjusted ea...
Get GH Research PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.